key: cord-0959468-unnvtrce
authors: Chang, Edward I.; Liu, Jesse Jun
title: Flattening the curve in oncologic surgery: Impact of Covid‐19 on surgery at tertiary care cancer center
date: 2020-06-02
journal: J Surg Oncol
DOI: 10.1002/jso.26056
sha: 4bd4643f86c52fce9af82317cc3d4d2bddd20bc2
doc_id: 959468
cord_uid: unnvtrce

INTRODUCTION: Covid‐19 has ushered in drastic changes to the healthcare system in order to “flatten the curve”; in particular, surgical operations that can consume vital, limited resources, not to mention the risk to staff, anesthesiologists, and surgeons. However, under unique circumstances with diligent preparation, vital oncologic operations can be performed safely. METHODS: Prospective comparison of surgical cases during the pandemic from December 2019 to May 2020 to the correlating time frame from December 2018 to May 2019. RESULTS: A significant decline in case volume was not appreciated until the United States declared a national state of emergency, allowing patients with cancer to continue to undergo curative tumor resection until then (428.3 ± 51.5 vs 166.6 ± 59.8 cases/week; P < .001). The decrease was consistent with the mean case volume during the holidays (213.8 ± 76.8 vs 166.6 ± 59.8 case/week; P = .648). Evaluation of surgical subspecialties demonstrated a significant decrease for all subspecialties with the greatest decline in sarcoma (P = .002) and endocrine (P = .001) surgeries, while vascular (P = .004) and thoracic (P = .011) surgeries had the least. CONCLUSIONS: The novel coronavirus has drastically reduced oncologic operations, but with proper evaluation of patients and allocation of resources, surgery can be performed safely without compromising the aim to flatten the curve and control the coronavirus pandemic.

The novel coronavirus (Covid-19) was first documented on 31 December 2019 in Wuhan, China with its initial index cases, followed by the first death on 11 January 2020. From there, the virus quickly engulfed the province and spread at unprecedented rates across the globe. [1] [2] [3] [4] The family of coronaviruses has a predilection for cross infection between humans and other zoonotic species, in this case bats, which culminated in viruses such as severe acute respiratory syndrome and Middle East respiratory syndrome, which humanity has never encountered in the past. 5, 6 Covid-19 presents with a cluster of pneumonia-like symptoms, often nonspecific including fever, malaise, nonproductive cough, and dyspnea, but can progress rapidly, in approximately 5.3 days, to acute respiratory distress requiring mechanical ventilation with a high mortality rate. 7, 8 On 30 January 2020, the World Health Organization (WHO) declared a global state of emergency and named the novel coronavirus Covid-19 on 11 February as the virus spread across the world from China to South Korea and Iran, and then Italy and eventually to the United States with the first case documented in Seattle, Washington on 20 January 2020. 9 With the massive outbreak that then ensued, the United States quickly surpassed other nations becoming the country with the most confirmed cases leading to restrictions and mandates from the Surgeon General and the American College of Surgeons canceling nonemergent surgeries and social distancing even in the hospital setting. 10, 11 With increasing data showing risks of patients undergoing surgery during the pandemic, potentially operating on infected patients, serious consideration was necessary to determine which operations are nonelective and justify the potential risks to patients, surgeons, anesthesiologists, nursing staff, and also taking into account the limited protective equipment and proper allocation of those resources.

In light of these serious considerations, difficult decisions are necessary at an institution that exclusively cares for patients with cancer. While there are recommendations for proper precautions, implementation of such protocols is hospital-dependent and based on the available protective equipment and also the patient population. 12 There is a relative paucity of studies examining the impact of Covid-19 on surgical treatment of malignancy. 13 The authors report on the effects of Covid-19 on surgical procedures at a tertiary care cancer center, and demonstrate that oncologic surgery can be performed safely for patients needing surgical extirpation for treatment of their malignancies. 

With the Surgeon General's announcement, along with recommendations from national societies, the University of Texas MD Anderson Cancer Center commenced reducing operative procedures and eliminated all elective cases on 16 March 2020. The initiative to conserve resources and reduce operative volume was further enforced with Texas Executive Order GA-09 on 24 March that prohibited all operations "not immediately medically necessary to correct a serious medical condition of, or to preserve the life of, a patient who without immediate performance of the surgery or procedure would be at risk for serious adverse medical consequences or death, as determined by the patient's physician."

As a precaution, a number of regulations were implemented to minimize risks to patients and staff being cognizant of limited resources. All cases were reviewed by departmental oversight committees to determine the validity of scheduled cases to remain in compliance with federal, Texas state, and institution mandates. Subgroup analysis of the different surgical specialties also saw a global decrease in the number of cases performed by each service mirroring the findings in the total number of cases performed each

week (Table 1 ). There was no surgical subspecialty that did not demonstrate a significant decrease in case volume. The service that demonstrated the most drastic reduction in cases was sarcoma (2.5 ± 1.6 vs 0.2 ± 0.4 cases/week; P = .002) followed by endocrine (9.8 ± 4.2 vs 1.6 ± 1.9 cases/week; P = .001) surgery. Of note, the volume of sarcoma cases at baseline are relatively lower given the rarity of disease, but other higher volume services were also found to have a drastic reduction in case volume such as hepatobiliary cases However, to provide care for patients who are typically older, with multiple comorbidities, and may be immunocompromised from radiation or chemotherapy, more stringent regulations were necessary and enforced to maintain the safety to patients and providers. As such restrictions were placed to limit visitors in the clinic as well as inpatient wards, masks were mandated for everyone, and temperature screening was performed everyone upon entry to the institution. 

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Edward I. Chang http://orcid.org/0000-0003-1067-9750

A novel coronavirus emerging in China-key questions for impact assessment

China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China

The novel coronavirus originating in Wuhan, China: challenges for global health governance

A new coronavirus associated with human respiratory disease in China

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

First case of 2019 novel coronavirus in the United States

Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Precautions for operating room team members during the COVID-19 pandemic

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Medically-necessary, timesensitive procedures: a scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic

Flattening the curve in oncologic surgery: Impact of Covid-19 on surgery at tertiary care cancer center